In biological assays, we showed that IGF1 requires both HIF-1α and GPER to induce VEGF-mediated endothelial tube formation, as evidenced by HUVECs cultured with conditioned medium obtained from CAFs and breast cancer cells treated with IGF1. The gene discussed is HIF1A; the disease is breast cancer.